Icosavax, Inc. logo

Icosavax, Inc.

NASDAQ:ICVX

Overview | Financials
Company Name Icosavax, Inc.
Symbol ICVX
Currency USD
Price 15.31
Market Cap 769,036,610
Dividend Yield 0%
52-week-range 4.75 - 16.105
Industry Biotechnology
Sector Healthcare
CEO Mr. Adam K. Simpson
Website https://icosavax.com

An error occurred while fetching data.

About Icosavax, Inc.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory

Related Stocks

Kezar Life Sciences, Inc. logo

Kezar Life Sciences, Inc.

KZR

6.84 USD

Utah Medical Products, Inc. logo

Utah Medical Products, Inc.

UTMD

61.58 USD

Aerovate Therapeutics, Inc. logo

Aerovate Therapeutics, Inc.

AVTE

2.63 USD

Mersana Therapeutics, Inc. logo

Mersana Therapeutics, Inc.

MRSN

1.42 USD

Theseus Pharmaceuticals, Inc. logo

Theseus Pharmaceuticals, Inc.

THRX

4.065 USD

Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc.

CMPX

1.52 USD

InterCure Ltd. logo

InterCure Ltd.

INCR

1.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD